Analystreport

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.

VALEANT PHARMACEUTICALS  (VRX) 
Last valeant pharmaceuticals earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.valeant.com